Highlights of AIDS 2014
Source: 20th International AIDS Conference (AIDS 2014)*

Slideset

Highlights of AIDS 2014

In this downloadable slideset, David A. Cooper, MD, DSc and Joel E. Gallant, MD, MPH, review key studies presented at the 2014 International AIDS Conference.
Format: Microsoft PowerPoint (.ppt)
File size: 2.00 MB
Date posted: 8/13/2014
  • ART Switch for Comorbidities in a Middle-Aged Black Woman

    Lisa Hightow-Weidman MD, MPH - 5/12/2017    1 comment / Last Comment: 6/16/2017
    One-tablet regimens may not always be the best choice of ART, but the best choice is always the one the patient is willing to take.
  • How New Data From CROI 2017 May Renew Interest in NNRTIs

    Charles B. Hicks MD - 4/21/2017    
    How do phase III data on doravirine affect the potential for future therapy with NNRTIs?
  • My Take on New PrEP Data From CROI 2017

    Charles B. Hicks MD - 4/27/2017    1 comment / Last Comment: 5/9/2017
    PrEP offers an important option for curtailing HIV transmission. This review of new data from CROI emphasizes what management considerations must accompany its use.
  • Optimizing ART for a Patient With PI Intolerance and a History of Resistance and Nonadherence

    Eric S. Daar MD - 6/21/2017    1 comment / Last Comment: 6/22/2017
    Would you switch a virologically suppressed patient who is experiencing PI toxicity to a PI-sparing regimen if they had history of nonadherence and resistance?
  • How New Data From CROI 2017 May Inform Switch Strategies in HIV-Infected Patients With Poor Bone Health

    Charles B. Hicks MD - 4/21/2017    
    Is switching TDF to TAF justified in osteopenic women?